Literature DB >> 11756237

Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat.

Djuana M E Harvell1, Tracy E Strecker, Benjamin Xie, Karen L Pennington, Rodney D McComb, James D Shull.   

Abstract

Because of the suggested role of energy consumption and the well-documented role of estrogens in the etiology of breast cancer, we have examined the effect of a 40% restriction of dietary energy consumption on the ability of administered 17beta-estradiol (E2) to induce mammary tumorigenesis in female ACI rats. Experiments herein test the hypothesis that at least part of the inhibitory effect of energy restriction on mammary tumorigenesis is exerted downstream of potential effects of dietary manipulation on the production of estrogens by the ovaries. Ovary-intact ACI rats were fed a control or a 40% energy-restricted diet and were either treated continuously with E2 from subcutaneous Silastic tubing implants or received no hormone treatment. Mammary cancers rapidly developed in E2-treated rats fed the control diet; within 216 days of initiation of E2 treatment 100% of the population at risk exhibited palpable mammary tumors. Dietary energy restriction markedly inhibited E2-induced mammary tumorigenesis, as evidenced by significant reductions in cancer incidence and tumor burden as well as a significant increase in the latency to the appearance of the first palpable cancer. The inhibitory actions of dietary energy restriction on E2-induced mammary tumorigenesis were associated with an inhibition of E2-stimulated mammary cell proliferation. However, this inhibition was insufficient to block induction of lobuloalveolar hyperplasia or appearance of focal regions of atypical epithelial hyperplasia. These data suggest that dietary energy restriction inhibits E2-induced mammary cancer by attenuating or retarding the progression of atypical hyperplasia to carcinoma. Expression of progesterone receptor (PR) was up-regulated within the focal regions of atypical hyperplasia and the carcinomas induced by E2, regardless of whether the rats were fed the control or energy-restricted diet. However, circulating progesterone was reduced by dietary energy restriction, suggesting a possible mechanism for inhibition of mammary tumorigenesis. Dietary energy restriction did not inhibit the ability of administered E2 to induce prolactin (PRL)-producing pituitary tumors and associated hyperprolactinemia, indicating that the inhibitory effects of dietary energy restriction on mammary tumorigenesis are tissue specific and independent of circulating E2 and PRL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756237     DOI: 10.1093/carcin/23.1.161

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18.

Authors:  Karen A Gould; Martin Tochacek; Beverly S Schaffer; Tanya M Reindl; Clare R Murrin; Cynthia M Lachel; Eric A VanderWoude; Karen L Pennington; Lisa A Flood; Kimberly K Bynote; Jane L Meza; Michael A Newton; James D Shull
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

2.  Ept7 influences estrogen action in the pituitary gland and body weight of rats.

Authors:  Scott G Kurz; Kirsten L Dennison; Nyssa Becker Samanas; Maureen Peters Hickman; Quincy A Eckert; Tiffany L Walker; Andrea S Cupp; James D Shull
Journal:  Mamm Genome       Date:  2014-01-22       Impact factor: 2.957

3.  Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.

Authors:  Tracy E Strecker; Thomas J Spady; Beverly S Schaffer; Karen A Gould; Amy E Kaufman; Fangchen Shen; Mac T McLaughlin; Karen L Pennington; Jane L Meza; James D Shull
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

4.  Nutrition and cancer: a review of the evidence for an anti-cancer diet.

Authors:  Michael S Donaldson
Journal:  Nutr J       Date:  2004-10-20       Impact factor: 3.271

Review 5.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

6.  Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross.

Authors:  James D Shull; Cynthia M Lachel; Clare R Murrin; Karen L Pennington; Beverly S Schaffer; Tracy E Strecker; Karen A Gould
Journal:  Mamm Genome       Date:  2007-09-18       Impact factor: 2.957

Review 7.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

8.  Rat strain specific attenuation of estrogen action in the anterior pituitary gland by dietary energy restriction.

Authors:  Djuana M E Harvell; Linda K Buckles; Karen A Gould; Karen L Pennington; Rodney D McComb; James D Shull
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

9.  Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.

Authors:  Rachel L Ruhlen; Dana M Willbrand; Cynthia L Besch-Williford; Lixin Ma; James D Shull; Edward R Sauter
Journal:  Breast Cancer Res Treat       Date:  2008-09-09       Impact factor: 4.872

10.  Association of cellular and molecular responses in the rat mammary gland to 17β-estradiol with susceptibility to mammary cancer.

Authors:  Lina Ding; Yang Zhao; Christopher L Warren; Ruth Sullivan; Kevin W Eliceiri; James D Shull
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.